Here's the Deal
Baird's Investment Banking Group is pleased to announce the following transaction:
Formulated Solutions, LLC (“Formulated Solutions”), supported by its minority investor HealthEdge Investment Partners, LLC (“HealthEdge”), has received an investment from Linden Capital Partners (“Linden”).
Founded in 1999, Formulated Solutions has long been known as one of the most innovative contract development and manufacturing companies (“CDMO”) in North America for over-the-counter (“OTC”) and prescription (“Rx”) healthcare products with a focus on complex topical and nasal formulations in semi-solid, aerosol, and liquid formats. With over 650 million units of annualized production capacity, Formulated Solutions exists to enhance products through creativity and invention, delivering its Marketing Partners unmatched formulations, innovative packaging, and cost-effective reliable supply of products. With partnerships with seven of the world’s top 12 Consumer Healthcare companies, the regulated products Formulated Solutions has developed and the brands it supports cover a global footprint of more than 45 countries, supported by numerous regulatory body registrations, including FDA, ANVISA, EMA, Health Canada, TGA, Korean Ministry, of Food and Drug Safety, UL, ISO and more. Formulated Solutions is headquartered in Largo, Florida.
HealthEdge Investment Partners, LLC is an operating-oriented private equity firm founded in 2005 that focuses exclusively on the healthcare industry. HealthEdge seeks to achieve superior returns by investing in businesses that benefit from the knowledge, experience, and network of relationships of its partners. HealthEdge’s partners have more than 100 years of combined operating experience in healthcare as CEOs and investors.
Linden Capital Partners is a middle market private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is one of the country’s largest dedicated healthcare private equity firms. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating experience, and (iii) its differentiated human capital program. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. Since its founding, Linden has invested more than $2.5 billion in healthcare companies. Linden is headquartered in Chicago, Illinois.
For additional information about this transaction, please contact: